New hope for slowing a rare brain disease
NCT ID NCT07173803
Summary
This is a clinical trial platform designed to test multiple new treatments for Progressive Supranuclear Palsy (PSP), a rare and serious brain disorder. It will start by testing two investigational drugs, AADvac1 and LM11A-31, to see if they are safe and can slow down the worsening of the disease. About 440 participants with early-stage PSP will be randomly assigned to receive either one of the study drugs or a placebo, and their symptoms and disease progression will be closely monitored.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROGRESSIVE SUPRANUCLEAR PALSY(PSP) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.